Atopic Dermatitis | Regeneron | REGN668

Pharmaceutical Company/Sponsor:

Regeneron

Code:

REGN668

Title:

An open-label study of dupilumab in patients with atopic dermatitis who participated in previous dupilumab clinical trials

Type:

Phase:

Condition/Disease:

Atopic Dermatitis

Intervention(s)/Treatment(s):

Status:

Completed

Link for Additional Information: